United States Drug Enforcement Administration

LONDON, Ky. – A Sunnyside, New York, man, Wilson Molina, 33, was sentenced on Monday, January 9, 2026, by U.S. District Judge Rober Wier to 120 months for conspiracy to distribute 400 grams of fentanyl and 500 grams or more of methamphetamine. 

According to his plea agreement, beginning in February 2024 and continuing through December 2024, Molina conspired with others to distribute controlled substances, including counterfeit pills containing fentanyl and methamphetamine. The fentanyl pills were manufactured to appear as if they were legitimate oxycodone 30mg pills; similarly, the methamphetamine pills mimicked the appearance of legitimate amphetamine and dextroamphetamine pills (commonly known by the brand name, “Adderall”. On multiple occasions, Molina supplied one of his co-conspirators with controlled substances that they then shipped into the Eastern District of Kentucky. Molina and his co-conspirators coordinated distribution of the fentanyl and methamphetamine from Queens, New York, maintaining massive quantities of the counterfeit pills in a storage unit close to Molina’s residence. On February 10, 2025, DEA executed a search warrant at a storage unit used to hold the drugs Molina was trafficking, and agents seized more than 3.4 million counterfeit pills.

Under federal law, Molina must serve 85 percent of his prison sentence. Upon his release from prison, he will be under the supervision of the U.S. Probation Office for 5 years. 

 Paul McCaffrey, First Assistant United States Attorney for the Eastern District of Kentucky, and Jim Scott, Special Agent in Charge, DEA, Louisville Field Division; jointly announced the sentencing. 

The investigation was conducted by the DEA. The U.S. Attorney’s Office was represented by Assistant U.S. Attorney Gregory Rosenberg.